Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Germany
(1,586/week)
France
(1,127/week)
Poland
(597/week)
Spain
(544/week)
Italy
(323/week)
View all
(7,380/week)
News
United States
(556/week)
Manufacturing
(438/week)
Energy
(282/week)
Technology
(393/week)
Other Manufacturing
(365/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Antiandrogen
Jun 22, 2020
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
May 15, 2020
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting
Apr 30, 2020
ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer
Mar 31, 2020
ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update
Feb 10, 2020
ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia
Sep 28, 2019
ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress
Aug 14, 2019
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019
Jul 15, 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
May 10, 2019
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019
May 04, 2019
Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting
Apr 17, 2019
ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
Apr 12, 2019
ESSA Pharma Grants Stock Options
Apr 02, 2019
Early Data from Phase 2 Trial Indicates Activity of Onvansertib in Prostate Cancer Patients Showing Initial Resistance to Anti-Androgen Therapy
Mar 28, 2019
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
Mar 13, 2019
Large Prospective Trial Validates Detection of AR-V7 Biomarker Using Epic Sciences' Platform to Predict Treatment Outcomes for Patients with Advanced Prostate Cancer
Feb 11, 2019
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
Oct 24, 2017
Polycystic Ovarian Syndrome Treatment Market Worth $5.1 Billion by 2025: Grand View Research, Inc.
Latest News
Mar 5, 2021
PG&E Self-Reports Small Number of Missed Inspections to CPUC; Takes Immediate Corrective Actions to...
Mar 5, 2021
Global Smart Label Materials Market Report 2021-2027: Packaging and ICT Industry Convergence Propels...
Mar 5, 2021
American Zinc Products Marks First Anniversary of Zinc Production
Mar 5, 2021
Arcimoto To Debut Roadster Prototype at 80th Annual Daytona Bike Week
Mar 5, 2021
Cerberus Appoints Gregory Nixon as Head of Strategic Investments
Mar 5, 2021
Valero Energy Corporation to Participate in Investor Conferences
Mar 5, 2021
Worldwide Vacuum Fillers Industry to 2026 - Rising Need to Increase the Shelf Life is Driving Growth -...
Mar 5, 2021
Global High Performance Fluoropolymers Market Forecasts to 2025 - 7% CAGR Forecast Between 2020 and 2025 -...
View all News
Agenda
17
November
London
Social Media in the Defence and Military Sector 2021, 17-18 November, London, UK
Now in its 10th year, SMi Group are pleased to present the Social Media in the Defence and Military Sector conference,...
20
September
United Kingdom
London
Future Armoured Vehicles Power Systems 2021, 20-21 September 2021, London, UK
As the shift from traditional power packs towards alternative means of vehicle propulsion accelerates, and armed forces...
15
September
United Kingdom
London
Defence Exports 2021, 15-16 September 2021, London, United Kingdom
SMi Group are delighted to announce that the fifteenth annual Defence Exports conference will convene on 15th – 16th...
View All Events